We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
CD3-specific antibodies: a portal to the treatment of autoimmunity.
- Authors
Chatenoud, Lucienne; Bluestone, Jeffrey A
- Abstract
Targeted immunotherapies hold great promise for the treatment and cure of autoimmune diseases. The efficacy of CD3-specific monoclonal antibody therapy in mice and humans stems from its ability to re-establish immune homeostasis in treated individuals. This occurs through modulation of the T-cell receptor (TCR)-CD3 complex (also termed antigenic modulation) and/or induction of apoptosis of activated autoreactive T cells, which leaves behind 'space' for homeostatic reconstitution that favours selective induction, survival and expansion of adaptive regulatory T cells, which establishes long-term tolerance. This Review summarizes the pre-clinical and clinical studies of CD3-specific monoclonal antibody therapy and highlights future opportunities to enhance the efficacy of this potent immunotherapeutic.
- Publication
Nature reviews. Immunology, 2007, Vol 7, Issue 8, p622
- ISSN
1474-1733
- Publication type
Journal Article
- DOI
10.1038/nri2134